Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H A Blacklock

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
British Medical Journal (Clinical Research Ed.)|August 6, 1983
Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trialI M Hann, H G Prentice, H A Blacklock, et al.
The New Zealand Medical Journal|February 13, 1980
Bone marrow transplantation in a child with acute lymphoblastic leukaemiaR S Hill, D C Mauger, P A Ockelford, et al.
Lancet (London, England)|April 10, 1982
Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patientsI M Hann, H G Prentice, R Corringham, et al.
Annals of Human Genetics|January 1, 1983
Absence of close linkage between Hereditary spherocytosis (SPH) and 24 genetic marker systems including HLA and GMB M de Jongh, H A Blacklock, P Reekers, et al.
The New England Journal of Medicine|February 22, 1996
Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study GroupJ R Berenson, A Lichtenstein, L Porter, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
British Medical Journal (Clinical Research Ed.)|August 6, 1983
Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trialI M Hann, H G Prentice, H A Blacklock, et al.
The New Zealand Medical Journal|February 13, 1980
Bone marrow transplantation in a child with acute lymphoblastic leukaemiaR S Hill, D C Mauger, P A Ockelford, et al.
Lancet (London, England)|April 10, 1982
Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patientsI M Hann, H G Prentice, R Corringham, et al.
Annals of Human Genetics|January 1, 1983
Absence of close linkage between Hereditary spherocytosis (SPH) and 24 genetic marker systems including HLA and GMB M de Jongh, H A Blacklock, P Reekers, et al.
The New England Journal of Medicine|February 22, 1996
Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study GroupJ R Berenson, A Lichtenstein, L Porter, et al.
Pageof 4